![William Fodor](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Vermögen: - $ am 31.05.2026
William Fodor is currently Chief Scientific Officer at Harvard Apparatus Regenerative Technology, Inc. since 2017.
Former positions include Chief Executive Officer at GlyGenix Therapeutics, Inc., Senior Director-Tissue Engineering at Alexion Pharmaceuticals, Inc., Senior Director-Product Development at ViaCell, Inc. from 2006 to 2008, and Associate Professor at the University of Connecticut from 2002 to 2005.
Education includes a doctorate from The Ohio State University.
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
| 21.04.2026 | 0 ( -.--% ) | - $ | 31.05.2026 |
| Unternehmen | Position | Beginn |
|---|---|---|
| HARVARD APPARATUS REGENERATIVE TECHNOLOGY INC. | Technik-/Wissenschafts-/F&E-Leiter | 01.07.2017 |
| Unternehmen | Position | Ende |
|---|---|---|
ViaCell, Inc.
 ViaCell, Inc. Medical SpecialtiesHealth Technology Provides and develops cellular medicine for the treatment of diseases | Corporate Officer/Principal | 01.07.2008 |
University of Connecticut
 University of Connecticut Other Consumer ServicesConsumer Services Functions as a College/University | Corporate Officer/Principal | 01.12.2005 |
| ALEXION PHARMACEUTICALS, INC. | Corporate Officer/Principal | - |
GlyGenix Therapeutics, Inc.
 GlyGenix Therapeutics, Inc. BiotechnologyHealth Technology Develops therapeutic products for the treatment of cure metabolic disorders | Vorstandsvorsitzender | - |
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
| Private Unternehmen | 6 |
|---|---|
Alexion Pharmaceuticals, Inc.
 Alexion Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Operates as a pharmaceutical company that develops life-changing therapies for people living with rare disorders | Health Technology |
ViaCell, Inc.
ViaCell, Inc. Medical SpecialtiesHealth Technology Provides and develops cellular medicine for the treatment of diseases | Health Technology |
Harvard Apparatus Regenerative Technology, Inc.
 Harvard Apparatus Regenerative Technology, Inc. Medical SpecialtiesHealth Technology Engages in the development and commercialization of medical devices | Health Technology |
The Ohio State University
 The Ohio State University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of Connecticut
University of Connecticut Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
GlyGenix Therapeutics, Inc.
GlyGenix Therapeutics, Inc. BiotechnologyHealth Technology Develops therapeutic products for the treatment of cure metabolic disorders | Health Technology |
Bitte wählen Sie Ihre Ausgabe
Alle länderspezifischen Finanzinformationen
